Furthermore, it has been reported that the transgenic introduction of sclerostin in ApoE−/− (SOSTTg.ApoE−/−) mice and the administration of recombinant sclerostin inhibited AngII-induced AA and atherosclerosis development. Here, SOST is linked to atherosclerosis.